Merck Sharp & Dohme LLC recalls Noxafil Powdermix (posaconazole) for Delayed-Release Oral Suspension
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Presence of particulate matter: potential presence of metal particulates in the product.
- Products
-
- Noxafil Powdermix (posaconazole) for Delayed-Release Oral Suspension
- Company
- Merck Sharp & Dohme LLC
- Where it was sold
-
Nationwide in the USA
Nationwide
- Units affected
- 845 kits
- About this recall
- Noxafil Powdermix (posaconazole) for Delayed-Release Oral Suspension, 300 mg, 8 packets per carton, Rx Only, Manufactured for: Merck Sharp & Doohme LLC, Rahway, NJ 07056 USA, Manufactured by: N.V. Organon, 5349 AB Oss, The Netherlands, a subsidiary of Organon & Co., Jersey City, NJ 07302, USA NDC 0085-2224-02.